1 results match your criteria crc-446

  • Page 1 of 1

Reduction of novel circulating long-chain fatty acids in colorectal cancer patients is independent of tumor burden and correlates with age.

BMC Gastroenterol 2010 Nov 29;10:140. Epub 2010 Nov 29.

Phenomenome Discoveries Inc, Saskatoon, Saskatchewan, Canada.

Background: Serum levels of novel hydroxy polyunsaturated ultra long-chain fatty acids (hPULCFAs) have been previously shown to be reduced in pre-treatment CRC patients compared to disease-free subjects, independent of disease stage. However, whether reduced levels of hPULCFAs result from the presence of cancer is currently unknown, as is the distribution of hPULCFAs in the general population. The following studies were carried out to assess whether conventional therapy would result in restoration of systemic hPULCFAs in CRC patients, and to investigate the relationship between hPULCFA levels and age. Read More

View Article and Full-Text PDF
November 2010
  • Page 1 of 1